The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): a case report and literature review

In patients without tissue availability at presentation, the analysis of cell-free DNA derived from liquid biopsy samples, in particular from plasma, represents an established alternative for providing epidermal growth factor receptor (EGFR) mutational testing for treatment decision-making. Compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Bao-Dong, Jiao, Xiao-Dong, Yuan, Ling-Yan, Liu, Ke, Wang, Zhan, Qin, Wen-Xing, Zang, Yuan-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091473/
https://www.ncbi.nlm.nih.gov/pubmed/30127622
http://dx.doi.org/10.2147/OTT.S167346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091473/
https://www.ncbi.nlm.nih.gov/pubmed/30127622
http://dx.doi.org/10.2147/OTT.S167346

Ejemplares similares